Representatives of the pharmaceutical giant Pfizer will be allowed continued access to the European Parliament, the leaders of the Parliament’s political groups decided on Thursday (16 February), after the company faced the risk of expulsion amid the ongoing controversy over the purchase of COVID vaccines.
The Pfizer and Moderna vaccines being used in the UK as boosters prompt the best overall response, according to a UK trial.
Pfizer has started making a vaccine against the omicron Covid variant, its chief executive confirmed on Monday.
Cases of coronavirus in Israel are rising despite widespread vaccination, indicating the Pfizer-BioNTech vaccine may only be 64 percent effective against the Delta variant of the virus.
Drugs giants Pfizer and AstraZeneca have rejected an NHS claim that the UK is facing a COVID-19 vaccine shortage, insisting there is no threat to supplies.
